Bluebird Bio Inc has seen a remarkable uptick in its share price, jumping 10.55% after the announcement of a new acquisition bid from Ayrmid Ltd. This unsolicited move, referred to as the "Ayrmid Proposal", consists of an immediate cash payout along with a potential performance-based payment related to the company's financial achievements.